Zero Margin for Error: Supply Chain Excellence in Ultra-Rare Gene Therapy with Almac Adapt™

Almac Clinical Services developed the Almac Adapt™ Just-in-Time Manufacturing Solution to address the growing complexity of advanced therapy supply chains. Designed for low-volume, patient-specific, and time-critical therapies, the solution replaces traditional forecast-led logistics with adaptive supply orchestration aligned to verified patient readiness and scheduling milestones.The solution was successfully implemented in a fast-tracked ultra-rare paediatric advanced therapy study requiring -80°C distribution and coordination with fixed surgical dosing windows. In this high-risk setting, precise execution was critical to maintaining uninterrupted treatment access.Almac Adapt™ integrates packaging, quality oversight, ultra-low temperature storage, distribution, and inventory stewardship through one coordinated operational solution supported by structured governance, real-time visibility, and proactive escalation. Operational simulation before live execution strengthened reliability and reduced risk. The study achieved zero temperature excursions, zero product loss, and on-time delivery aligned with scheduled surgical procedures.As advanced therapies continue to reshape pharmaceutical development, Almac Adapt™ provides a scalable and repeatable solution for future supply chains, demonstrating how adaptive execution, precision coordination, and operational excellence can directly support successful treatment delivery.